molecular modeling

Antibody Solutions helps biopharmaceutical companies advance their discovery of better diagnostics and therapeutics by delivering fit-for-purpose antibodies. With more than 30 years of history, the company provides antibody discovery and production services under a fee-for-service, pay-as-you-go model that keeps client IP in their hands.

affinity purificationantibody discoveryantibody manufacturingantigen developmentassay developmentB-cell fusionbioconjugationFlow Cytometryhybridoma generationmonoclonal antibody discoverypolyclonal antibody discoverysequencing

ARIScience uses its AI+QQ process, unifying AI, quantum chemistry, computer vision, and biochemistry, to design and discover small molecule compounds that interrupt disease pathways. It pursues treatments for neurodegenerative, inflammatory, and infectious diseases, and was awarded a BARDA small molecule research contract in April 2023, completed in October 2024.

AI and quantum chemistry (AI+QQ) in silico drug discoveryin vitro assays (FRET, thermal shift, ITC)in vivo murine model confirmation via CROsmachine learningvirtual screening

ATTMOS Inc. develops scientific software, research platforms, and computational workflows for drug discovery and research teams. Founded in 2022 by academics, the company combines molecular modeling, scientific software, and scalable computing with direct scientific collaboration to tackle challenging problems in drug discovery.

AI/ML-enabled drug discoveryforce field developmenthigh-performance computingmolecular dynamics simulationsprotein-ligand modelingQM/MM simulationsquantum chemistryscientific software development

Chemestmed is an Estonian biotech company developing first-in-class drugs to treat CNS and metabolic diseases and disorders. It works in epitranscriptomics, developing a technological platform for discovery of novel drugs based on mRNA regulation in cells, including small-molecule activators targeting the METTL3/METTL14 methyltransferase complex to enhance RNA m⁶A methylation.

cell-based assay developmentCRISPR/Cas9 gene editingenzyme assaysepitranscriptomics researchin vitro cell cultureNMR analysisorganic synthesisquantum chemistry calculationssmall molecule drug discoveryvirtual screening

ChemoGenics BioPharma is a drug discovery research and service organization providing preclinical drug discovery services to pharmaceutical, biotechnology, academic and government institutions globally. It has facilities in the Research Triangle Park Area in the United States and serves clients in the U.S. and Europe. Its core team has 10+ years of experience in preclinical drug discovery, with strengths in medicinal chemistry, cheminformatics, bioinformatics, ADMET and in vivo pharmacology in metabolic disease, oncology and inflammation.

analytical chemistryBioinformaticscGMP manufacturing of APIcheminformaticscloningcomputer-aided drug designcustom synthesisin vitro ADMEIn vivo PK/PDmedicinal chemistryProcess optimization and scale upRecombinant protein synthesis

Clariant is one of the world's leading specialty chemical companies, contributing to value creation with innovative and sustainable solutions for customers from many industries. It reports in three business units: Care Chemicals, Adsorbents & Additives, and Catalysts. On 31 December 2025, the company employed a total workforce of 10,281 across 73 production sites.

chemical synthesislab validationproductionresearch and developmenttoll manufacturing